We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Corporate Advert

FDA Submits New CBD Policies to White House for Review

If given approval, the new regulations could come into effect in a matter of weeks.

Read More

Hemp Pet Products Recalled Due to High Lead Levels, FDA Announces

A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.

Read More

Nebraska Approves its First Hemp Testing Lab

Cannabis Testing Laboratories, which received ISO-certification in early July, was later added to Nebraska’s Department of Agriculture’s list of approved hemp testing facilities.

Read More

Covid-19 and the Cannabis Supply Chain: A Q&A With Vanguard Scientific

With many businesses now experiencing disruption caused by the ongoing coronavirus pandemic, Matthew Anderson of Vanguard Scientific tells Analytical Cannabis of his experiences working in the supply chain over the past several months.

Read More

Why Do Some Hemp Crops Produce Too Much THC? This New Study Aims to Find Out

Which factors are tipping these THC concentrations over the legal limit? The soil? The sun? The strain? Right now, it’s not entirely clear. But one research group at West Virginia University want to change that.

Read More

Rhode Island Licenses its First Medical Cannabis Lab

Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.

Read More

European Commission Considers Reclassifying CBD as a Narcotic

The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.

Read More

Cannabis Could be a Promising Treatment for Sickle Cell Disease, Clinical Trial Concludes

The disease's painful symptoms are often treated with prescription opioids. But a new clinical trial has found that cannabis could be a promising, and safer, substitute.

Read More

CBD in the UK: Predictions for 2021

For all the excitement, the UK’s CBD industry is actually facing a roadblock, writes Professor Mike Barnes.

Read More

Advertisement